Lauroyl Aripiprazole API

Name	Lauroyl aripiprazole
Chinese name	月桂酰阿立派唑
Cas Number	1259305-29-7
Source	India
Qualifications	-/-/-/-/-

Lauroyl aripiprazole is a new type of aripiprazole long-acting injections (LAIs), which was approved by the FDA in October 2015 for the treatment of adult schizophrenia. Lauroyl aripiprazole works by binding to partially agonizing D2 and 5-HT1 A receptors and antagonizing 5-HT2 A receptors. The results of clinical studies have shown that lauroyl aripiprazole has a significant effect on patients with schizophrenia, including those with hostile and aggressive behavior, and this anti-hostile effect seems to be independent of general antipsychotic effects. The study also suggests that continued treatment with lauroyl aripiprazole will improve the patient’s aggressive symptoms; compared with placebo, the PANSS agonistic score of non-responders of lauroyl aripiprazole improved significantly from baseline, suggesting that this improvement is independent The effect on the total score of PANSS. According to data from sample hospitals in China, China's domestic use of drugs for mental disorders rose from 2.47 billion yuan in 2012 to 5.13 billion yuan in 2018. The overall market has grown 2.1 times in six years, with a compound growth rate of 13.0%. The market is growing well.

Hot Tags: lauroyl aripiprazole api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Tetrabenazine API, Clofarabine API, Solinasine Succinate API, Pregabalin API, Active Pharmaceutical Ingredient, Paliperidone API

• Previous: Vigabatrin API
• Next: Ramipril API